Connective tissue disease (CTD) groups together various disorders, such as rheumatoid arthritis and lupus. A new study from the University of Chicago found that complications from these diseases are more prominent based on race.
Blood analysis in patients with inflammatory rheumatic diseases such as psoriatic arthritis indicates that biologic medications do not reduce the efficacy of anti-pneumococcal polysaccharide vaccine, and that patients with such conditions may not need to be vaccinated more frequently than others.
Finding treatments for rheumatoid arthritis has proven to be a challenge in the medical community but researchers have found a potential way to help predict whether a medication will be effective in this patient population.
Investigators looking to compare the risks of 13 different targeted immunomodulators gathered 51 observational studies and 10 randomized controlled trials that made head-to-head comparisons. Most of the studies involved patients with rheumatoid arthritis but the underlying research also included patients with ankylosing spondylitis, inflammatory bowel diseases, juvenile idiopathic arthritis, plaque psoriasis, psoriatic arthritis